Stephan C, Albuquerque B, Schreiber S. Authors' Reply to Letter to the Editor Regarding 'Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNE HIV Med 2025 Dec 1. doi: 10.1111/hiv.70159.
PMID: 41327554